Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

The error here is your hypothetical scenario. Statistically we don't have those numbers, which means that with super small "n" values (probably less than 8 in each of those arms pertaining to time to recover from ventilator), any finding can be due to random chance in the absence of the statistical power we need which would be derived in a larger trial. Which is why I am saying we need phase 3.

The problem here is this sort of data mining represents post-hoc analysis and is not held in the same regard as finding signal in primary endpoint